{
  "id": "SCR-LIP-000619",
  "statement": "Neuropathic pain features are frequently reported in lipedema and may be more common in advanced stages.",
  "claim_type": "clinical_association",
  "context": {
    "population": "118 women with lipedema (n=62) or bilateral lower-extremity lymphedema (n=56)",
    "condition": "lipedema",
    "exposure": "lipedema diagnosis",
    "comparator": "lymphedema patients",
    "outcome": "neuropathic pain features (painDETECT, LANSS), pain severity (VAS), anxiety/catastrophizing",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "title": "Neuropathic Pain Features in Lipedema Compared to Lymphedema: An Exploratory Cross-Sectional Study.",
      "authors": "Pervane S, Uzun Ö.",
      "ref": "DOI:10.1177/15578585261454778",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": false,
      "quote": "Lipedema patients reported higher pain severity (VAS 6.2 ± 1.4 vs. 5.5 ± 1.5, p = 0.02) and greater neuropathic pain prevalence (42% vs. 21%, p < 0.01) than lymphedema.",
      "extraction_confidence": "high",
      "note": "The article documents a high burden of neuropathic chronic pain features and associated anxiety/catastrophizing in lipedema, supporting an association with chronic-pain phenomena, but it does not test fibromyalgia specifically, so it refine",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article is an exploratory cross-sectional study of 118 women (62 lipedema, 56 lymphedema), reports neuropathic pain prevalence of 42% vs 21%, higher painDETECT/LANSS scores in lipedema,",
        "date": "2026-06-28"
      },
      "stance_in_source_claim": "refines",
      "finding": "In 118 women, lipedema patients had higher pain severity (VAS 6.2 vs 5.5, p=0.02) and neuropathic pain prevalence (42% vs 21%, p<0.01) than lymphedema patients.",
      "from_claims": [
        "SCR-LIP-000404"
      ]
    },
    {
      "title": "Multidimensional Assessment of Pain and Related Factors In Lipedema: A Controlled Clinical Study.",
      "authors": "Gümrük Aslan S, Barış Saklica Ş, Borman P.",
      "ref": "DOI:10.1177/15578585261508256",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": false,
      "quote": "Patients with lipedema demonstrated clinically relevant pain and neuropathic pain features.",
      "extraction_confidence": "high",
      "note": "The study characterizes pain and neuropathic pain in lipedema but does not test association with fibromyalgia or other named chronic-pain conditions, so it is on-topic background rather than a direct test of the comorbidity relationship.",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article is a controlled study of 20 lipedema women vs 20 controls assessing pain (VAS, LANSS, DN4) with the exact correlations stated (ρ=0.529, p=0.017 and ρ=0.521, p=0.018), and it does not assess fibromyalgia or other chronic-pain com",
        "date": "2026-11-17"
      },
      "stance_in_source_claim": "context",
      "finding": "In 20 women with lipedema vs 20 healthy controls, lipedema patients showed clinically relevant pain and neuropathic pain features (VAS, LANSS, DN4); LANSS correlated with VAS (rho=0.529).",
      "from_claims": [
        "SCR-LIP-000466"
      ]
    },
    {
      "title": "Screening for lipedema in women with lower extremity pain and its associations with functional status, pain, mood, and quality of life: A questionnaire-based case–control study",
      "ref": "DOI:10.1177/02683555261490379",
      "stance": "supporting",
      "study_design": "case_control",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": false,
      "quote": "Mulheres com dor em membros inferiores tiveram escores de LSQ maiores e mais lipedema provável que controles (36,8% contra 12,3%; p = 0,001)",
      "extraction_confidence": "high",
      "note": "Study links lipedema probability with chronic lower-extremity and neuropathic pain, supporting an association, but it is screening-based (LSQ not diagnostic) and addresses neuropathic pain rather than fibromyalgia specifically, so it refine",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "All specific numbers and findings in the statement (36.8% vs 12.3%, p=0.001; r=0.446, p<0.001; β=0.382, p=0.004) are directly present in the article abstract and results. The statement accurately reflects the source's findings about lipedem",
        "date": "2026-11-17"
      },
      "stance_in_source_claim": "refines",
      "finding": "Among women with lower extremity pain, probable lipedema was more frequent than in controls (36.8% vs 12.3%, p=0.001); PainDETECT independently associated with LSQ score (beta=0.382, p=0.004).",
      "from_claims": [
        "SCR-LIP-000463"
      ]
    },
    {
      "ref": "DOI:10.3390/ijms231810313",
      "stance": "refines",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2022,
      "amato_authored": false,
      "note": "The article characterizes pain mechanisms (peripheral neuropathic pain, dermal hypersensitivity, neurogenic inflammation) within lipedema across stages, supporting lipedema as a chronic-pain condition, but it does not examine fibromyalgia o",
      "title": "Indications of Peripheral Pain, Dermal Hypersensitivity, and Neurogenic Inflammation in Patients with Lipedema",
      "authors": "Chakraborty et al.",
      "journal": "International Journal of Molecular Sciences",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "The statement accurately reflects findings from this source: stage-dependent pain prevalence (60-100%), painDETECT >19 only in Stage 3, von Frey hypersensitivity in calf/thigh for Stage 2-3, reduced abdominal Tuj-1+ neuronal density, elevat",
        "date": "2026-06-10"
      },
      "quote": "painDETECT cumulativo: 11,0±5,2 (S1) vs 10,5±4,9 (S2) vs 17,6±7,2 (S3); p=0,0271; apenas Stage 3 apresentou respondedores >19 (dor neuropática)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "refines",
      "finding": "painDETECT scores were higher in stage 3 (17.6) than stages 1-2 (11.0, 10.5; p=0.0271), with neuropathic responders only in stage 3; cutaneous hypersensitivity and CGRP/NGF increased with stage.",
      "from_claims": [
        "SCR-LIP-000147"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000404",
    "SCR-LIP-000466",
    "SCR-LIP-000463",
    "SCR-LIP-000147"
  ],
  "questions_consolidated": [
    "SQ-LIP-000008"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00068",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000008"
    }
  ],
  "statement_pt": "Características de dor neuropática são frequentemente relatadas no lipedema e podem ser mais comuns em estágios avançados.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000008",
      "role": "supporting",
      "question": "Is lipedema associated with fibromyalgia and other chronic-pain conditions?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000008.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000619.html"
}